Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Diabetic Macular Edema · Hypercholesterolemia · REGN

Regeneron UK

Regeneron UK Limited

Regeneron UK clinical programs — 493 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Tarrytown, USA HQ
16,715 Employees
Public company Type
REGN · NYSE Ticker
Company details
Status
Public
HQ
Tarrytown, USA
Employees
16,715
Programs
493
Drugs
98
Patents
837
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Regeneron UK projects

493 ClinicalTrials.gov programs sponsored by Regeneron UK.

Regeneron UK has 493 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

493 programs

Clinical programs

Page 9 of 11

  1. REGN3918

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. REGN421(SAR153192)

    Regeneron UK Limited

    Advanced Solid Malignancies

    phase 1 small molecule completed

    1 trial

  3. REGN4461

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. REGN4659

    Regeneron UK Limited

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule terminated

    1 trial

  5. REGN475 (SAR164877)

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  6. REGN5069

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  7. REGN5093-M114

    Regeneron UK Limited

    Advanced NSCLC

    phase 1 small molecule terminated

    1 trial

  8. REGN5381

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  9. REGN5678

    Regeneron UK Limited

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  10. REGN5713-5714-5715

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. REGN6490

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule terminated

    2 trials

  12. REGN6569

    Regeneron UK Limited

    Squamous Cell Carcinoma of Head and Neck

    phase 1 small molecule terminated

    1 trial

  13. REGN668

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  14. REGN668

    Regeneron UK Limited

    Dermatitis

    phase 1 mab completed

    1 trial

  15. REGN668: Injection Rate 1

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  16. REGN7257

    Regeneron UK Limited

    Severe Aplastic Anemia (SAA)

    phase 1 small molecule terminated

    1 trial

  17. REGN727

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  18. REGN727

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  19. REGN727(SAR236553)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 1 small molecule completed

    1 trial

  20. REGN728

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  21. REGN7508 (IV)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  22. REGN7544

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. REGN7999

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  24. REGN846

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  25. REGN88

    Regeneron UK Limited

    Rheumatoid Arthritis

    phase 1 mab completed

    3 trials

  26. REGN9035

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  27. REGN9533

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  28. REGN9933

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  29. Rilonacept

    Regeneron UK Limited

    Autoimmune Neurosensory Hearing Loss (ANSHL)

    phase 1 small molecule active

    1 trial

  30. SAR231893 (REGN668)

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  31. SAR231893 (REGN668) DP1

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  32. SC-DARIC33

    Regeneron UK Limited

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  33. Subconjunctival aflibercept

    Regeneron UK Limited

    Corneal Neovascularization

    phase 1 small molecule terminated

    1 trial

  34. VEGF Trap

    Regeneron UK Limited

    Neovascular Age Related Macular Degeneration

    phase 1 small molecule completed

    1 trial

  35. VEGF Trap

    Regeneron UK Limited

    Macular Degeneration

    phase 1 small molecule completed

    1 trial

  36. VEGF Trap-Eye

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 1 small molecule completed

    1 trial

  37. Vonsetamig

    Regeneron UK Limited

    Lupus Nephritis (LN)

    phase 1 small molecule active

    1 trial

  38. aflibercept

    Regeneron UK Limited

    Lymphoma, Non-Hodgkin

    phase 1 small molecule completed

    1 trial

  39. aflibercept (AVE0005)

    Regeneron UK Limited

    Neoplasms

    phase 1 small molecule completed

    2 trials

  40. aflibercept (AVE0005)

    Regeneron UK Limited

    Cancer

    phase 1 small molecule completed

    1 trial

  41. bbT369

    Regeneron UK Limited

    Diffuse Large B Cell Lymphoma (DLBCL)

    phase 1 mab terminated

    1 trial

  42. cemiplimab

    Regeneron UK Limited

    Relapsed/Refractory Aggressive B-Cell Lymphoma

    phase 1 small molecule active

    1 trial

  43. linvoseltamab

    Regeneron UK Limited

    Food Allergy

    phase 1 small molecule active

    1 trial

  44. nesvacumab (REGN910/ SAR307746)

    Regeneron UK Limited

    Solid Tumors

    phase 1 small molecule completed

    2 trials

  45. rilonacept (IL-1 Trap)

    Regeneron UK Limited

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule completed

    1 trial

  46. ziv-aflibercept

    Regeneron UK Limited

    Cancer

    phase 1 mab completed

    2 trials

  47. ziv-aflibercept

    Regeneron UK Limited

    Lymphoma

    phase 1 mab completed

    2 trials

  48. 16995

    Regeneron UK Limited

    Neovascular Macular Degeneration

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Regeneron UK have?

493 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.